Effectiveness of bortezomib and bortezomib-containing programs FOR the treatment of recurrent and resistant multiple myeloma

by T A Mitina, A K Golenkov, E V Katayeva, T D Lutskaya, E V Trifonona, E F Klinushkina
Published 2010-07-01

ASSESSMENT OF THE RESIDUAL TUMOR IN PATIENTS WITH MULTIPLE MYELOMA BASED ON THE ANALYSIS OF THE FREE LIGHT CHAINS OF IMMUNOGLOBULINS IN BLOOD SERUM

by T. A. Мitina, A. K. Golenkov, A. Yu. Baryshnikov, A. V. Karaulov, E. V. Trifonova, Yu. B. Chernykh, E. V. Katayeva, T. D. Lutskaya, L. L. Vysotskaya, G. A. Dudina, S. G. Zacharov, A. M. Fomin, N. V. Lyubimova, I. N. Kogarko
Published 2016-02-01